Baillie Gifford - MENLO THERAPEUTICS INC ownership

MENLO THERAPEUTICS INC's ticker is MNLO and the CUSIP is 586858102. A total of 94 filers reported holding MENLO THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is 1.10 and the average weighting 0.2%.

Quarter-by-quarter ownership
Baillie Gifford ownership history of MENLO THERAPEUTICS INC
ValueSharesWeighting
Q2 2020$683,000
+95.7%
395,049
+204.0%
0.00%
Q1 2020$349,000129,9710.00%
Other shareholders
MENLO THERAPEUTICS INC shareholders Q1 2020
NameSharesValueWeighting ↓
DSC Advisors, L.P. 2,075,753$5,563,0005.43%
Healthcare Value Capital, LLC 850,000$2,278,0003.83%
venBio Partners LLC 1,461,552$3,917,0003.34%
Vivo Capital, LLC 3,843,824$10,301,0000.93%
683 Capital Management, LLC 3,995,222$10,708,0000.63%
Parkman Healthcare Partners LLC 406,383$1,089,0000.50%
GREAT POINT PARTNERS LLC 1,652,013$4,427,0000.46%
Perceptive Advisors 6,637,179$17,456,0000.46%
MANGROVE PARTNERS IM, LLC 1,054,143$2,825,0000.39%
Sofinnova Investments, Inc. 604,829$1,621,0000.15%
View complete list of MENLO THERAPEUTICS INC shareholders